Low Testosterone Levels Predict Incident Depressive Illness in Older Men: Effects of Age and Medical Morbidity
The DOI matches its Crossref record, with a small difference in title or year.
Abstract
OBJECTIVE: Prior studies found that chronic low testosterone levels are associated with an increased risk of depression. We investigated whether low testosterone levels in older men predict depressive illness over 2 years, while controlling for age and medical morbidity. METHOD: Participants were 748 men, aged 50 years or older, without prior ICD-9-diagnosed depressive illness, with a testosterone level obtained between 1995 and 1997. Measures were age, mean total testosterone levels (low: < or = 2.5 ng/mL), medical morbidity, and incidence and time to depressive illness. RESULTS: Men with low testosterone levels had a greater 2-year incidence of depressive illness (18.5% vs. 10.4%, df = 1, p = .006) and a shorter time to onset of depressive illness (log-rank chi(2) = 8.1, df = 1, p = .004). The unadjusted hazard ratio (HR) for depressive illness in men with low testosterone levels was 1.9 (95% confidence interval [CI] = 1.2 to 3.0, p = .005). After adjustment for age and medical morbidity, men with low testosterone levels continued to have a shorter time to depressive illness (adjusted HR = 2.1; 95% CI = 1.3 to 3.2, p = .002). Due to a significant interaction between age and medical morbidity, we conducted stratified Cox regression analyses and found that low testosterone levels and high medical morbidity or an age of 50 to 65 years were associated with increased depressive illness (p = .002). CONCLUSION: Low testosterone levels are associated with an earlier onset and greater incidence of depressive illness. Men with low testosterone levels who had high medical morbidity or were aged 50 to 65 years had an increased risk for depressive illness. Further prospective studies are needed to examine the role of testosterone in depressive illness in older men.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given that testosterone increases competitive tendencies (Mehta et al., 2009;Mehta and Josephs, 2006), low plasma testosterone levels in the depressed patients (Shores et al., 2005) might also be associated with competition avoidance.”
From Social functioning in major depressive disorder (2016) · cites this paper as Shores et al., 2005
Citations
Cites
Still being checked.
Cited by
Items 101–166 of 166
Depression-like behavior and reduced plasma testosterone levels in the senescence-accelerated mouse
Egashira, N., Koushi, E., Okuno, R., Shirakawa, A., Mishima, K., Iwasaki, K., Oishi, R., & Fujiwara, M. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.030 · Cited by 12
Plasma androgens and the presence and course of depression in a large cohort of men
de Wit, A. E., Giltay, E. J., de Boer, M. K., Nolen, W. A., Bosker, F. J., Penninx, B. W. J. H., & Schoevers, R. A. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105278 · Cited by 12
Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea
Ko, Y. H., & Kim, J. J. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2010.124 · Cited by 12
The behavioral correlates of testosterone
Bancroft, J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.006 · Cited by 12
Testosterone for ‘late-onset hypogonadism’ in men?
(2010) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2010.01.0004 · Cited by 10
Pubertal emergence of testosterone effects on depressive symptoms in boys
Culbert, K. M., Roa, A. M., Stevens, K. S., Sisk, C. L., Burt, S. A., & Klump, K. L. (2022) · JCPP Advances · doi:10.1002/jcv2.12088 · Cited by 10
Boylu, M. E., Turan, Ş., Güler, E. M., Boylu, F. B., Kılıç, Ö., Koçyiğit, A., & Kırpınar, İ. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01704-9 · Cited by 11
Nguyen, T. M. L., Jollant, F., Tritschler, L., Colle, R., Corruble, E., & Gardier, A. M. (2023) · Pharmaceuticals · doi:10.3390/ph16040634 · Cited by 11
Attractin Participates in Schizophrenia by Affecting Testosterone Levels
Li, N., Gao, S., Wang, S., He, S., Wang, J., He, L., Jiang, D., Shi, Y. S., Zhang, J., Gu, Y., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.755165 · Cited by 8
Kapfhammer, H. P. (2006) · Der Internist · doi:10.1007/s00108-006-1704-x · Cited by 9
Testosterone replacement therapy in the ageing man
Buvat, J., & Boujadoué, G. (2005) · The Journal of Men s Health and Gender · doi:10.1016/j.jmhg.2005.09.001 · Cited by 7
Hebbrecht, K., Morrens, M., Neels, H. M., Roosens, L., & Sabbe, B. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1515911 · Cited by 9
Risk factors for late-onset hypogonadism
Yang, Q., Wu, K., Li, Z.-Q., Li, W. C., Lü, L., Wu, H., Zhuang, Y., & Sui, X. (2018) · Andrologia · doi:10.1111/and.13016 · Cited by 6
Kong, Z., Jiang, J., Deng, M., Zhang, Z., & Wang, G. (2020) · Medicine · doi:10.1097/md.0000000000019316 · Cited by 6
McGuirt, A. F., & Brezing, C. (2024) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2023.2292012 · Cited by 6
Männer-Depression: Ein vernachlässigtes Thema - ein therapeutisches Problem
Wolfersdorf, M., Schulte-Wefers, H., Straub, R., & Klotz, T. (2006) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 6
Testosterone and male rejuvenation
Helo, S., Thomas, P., & Tadros, N. N. (2019) · Panminerva Medica · doi:10.23736/s0031-0808.18.03513-9 · Cited by 5
Leão, R. D. C. H., Silva, V. D. L., & Moreira, R. D. S. (2017) · Revista Brasileira de Geriatria e Gerontologia · doi:10.1590/1981-22562017020.160159 · Cited by 5
Ransome, M. (2012) · Neural Regeneration Research · doi:10.3969/j.issn.1673-5374.2012.028.009 · Cited by 7
Herzog, A. G. (2009) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000300023.30532.d3 · Cited by 4
Rybka, K. A., Lafrican, J. J., Meunier, P., Reilly, D. M., Parra, K. E., Colón, L. M., Poulos, A. M., & Zuloaga, D. G. (2025) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2025.107554 · Cited by 3
Impact of High-Deductible Health Plans on Medication Use Among Individuals With Bipolar Disorder
Lu, C. Y., Busch, A. B., Zhang, F., Madden, J. M., Callahan, M. X., LeCates, R. F., Wallace, J., Foxworth, P. M., Soumerai, S. B., Ross‐Degnan, D., et al. (2021) · Psychiatric Services · doi:10.1176/appi.ps.202000362 · Cited by 6
Colangelo, L. A., Carroll, A. J., Perak, A. M., Gidding, S. S., Lima, J. A. C., & Lloyd‐Jones, D. M. (2024) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001277 · Cited by 2
Testosterone prescribing in men with depression and anxiety disorders
Javed, Z., Kuo, Y., Temple, J. R., Urban, R. J., Holmes, H. M., & Baillargeon, J. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.05.015 · Cited by 6
Development of Men's Depressive Symptoms: A Systematic Review of Prospective Cohort Studies
Scholz, B., Crabb, S., & Wittert, G. (2013) · Journal of Men s Health · doi:10.1089/jomh.2012.00066 · Cited by 5
Androgen deficiency in aging men
T'Sjoen, G. G., & Kaufman, J. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224805.31695.6a · Cited by 3
Causas orgánicas y comórbidas de la depresión: el primer paso
Campagne, D. M. (2012) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2011.12.010 · Cited by 5
Shores, M. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-54482-9_12 · Cited by 3
Self-citationTagarakis, G. I., Tsolaki-Tagaraki, F., Tsolaki, M., Diegeler, A., Stylianakis, G. E., Kazis, D. A., Tsilimingas, N. B., & Papassotiropoulos, A. (2008) · Journal of Cardiac Surgery · doi:10.1111/j.1540-8191.2008.00577.x · Cited by 2
Benefits and Risks of Testosterone Therapy in Men With Testosterone Deficiency
Traish, A. M., & Morgentaler, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813197-8.00018-x · Cited by 2
Impact of Testosterone Deficiency and Testosterone Therapy on Men’s Health
Traish, A. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_13 · Cited by 1
Avolition in a patient with hypogonadism
Verhoeven, W. M. A., Tuinier, S., Egger, J. I. M., van Erp, F., & Tuerlings, J. H. A. M. (2008) · The European Journal of Psychiatry · doi:10.4321/s0213-61632008000400002 · Cited by 1
Diagnosing and treating bipolar disorder in primary care
Koirala, P., & Anand, A. (2018) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.85gr.18003 · Cited by 2
Dessoki, H. H., Soltan, M. R., & Ezzat, A. A. (2018) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000542410.42664.c7 · Cited by 1
Laux, G. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_67 · Cited by 3
Effect of Fluoxetine hydrochloride on the hormonal profile
Pushkar, B. K., & Sivabalan, R. (2015) · Annals of Applied Bio-Sciences · Cited by 1
Traish, A. M. (2015) · Current Sexual Health Reports · doi:10.1007/s11930-015-0061-y · Cited by 2
The Relationship Between Testosterone and Mortality in Men: A Debatable Issue
Paparrigopoulos, T. J., Tzavellas, E., Karaiskos, D., & Liappas, I. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.95 · Cited by 2
Long-Term Morbidity of Late-Onset Hypogonadism
Behre, H. M. (2005) · European Urology Supplements · doi:10.1016/j.eursup.2005.05.003 · Cited by 1
Considering Wellness in Managing Patients with Bipolar Disorder
McIntyre, R. S. (2008) · CNS Spectrums · doi:10.1017/s1092852900003102 · Cited by 1
Gonadal hormone effects on mental disorders across development
Stevens, K. S., Anaya, C., & Culbert, K. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91497-0.00172-7 · Cited by 1
Kristianingrum, Y. P. (2014)
Más controversias en el tratamiento con testosterona
Rajmil, O. (2014) · Revista Internacional de Andrología · doi:10.1016/j.androl.2014.10.001
Impact of Testosterone Levels and Treatment on Aging Men’s Health: Should We Worry?
Barqawi, A. B., Gewehr, E. V., Akduman, B., & Crawford, E. D. (2005) · Aging Health · doi:10.2217/1745509x.1.2.253
Current awareness in geriatric psychiatry
Gillies, B. (1994) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930090415
Androgens and neuroplasticity : contributions to the pathogenesis and treatment of depression
Wainwright, S. R. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0221360
Scholz, B. (2015) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Antiaging and Performance-Enhancing Drugs
Yaseen, Z. (2018) · Springer eBooks · doi:10.1007/978-3-319-16223-2_6
Pharmacosexology: Psychiatric Side Effects of Drugs for the Treatment of Sexual Dysfunction
Abdo, C. H. N. (2018) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-68306-5_20
Abd-Elrahman, M. N. A., Fouad, A. A., & Salah, H. (2019) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_63_18
The Influence of Physical Exercises on Psychic Disorders
Hagiu, B.-A. (2019) · Journal of Sports Science · doi:10.17265/2332-7839/2019.02.003
Current awareness in geriatric psychiatry
(2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1227
Laux, G. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_67-1 · Cited by 1
Laux, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_55
Laux, G. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_55
Salminen, E. K., Portin, R. I., & Nurmi, M. (2007) · Clinical medicine Oncology · doi:10.1177/117955490700100005
Benefits of Testosterone Therapy on Mood and Well-Being
Zitzmann, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_22
Zhang, L., Verwer, R. W. H., van Heerikhuize, J. J., Lucassen, P. J., Nathanielsz, P. W., Hol, E. M., Aronica, E., Dhillo, W. S., Meynen, G., & Swaab, D. F. (2024) · Figshare · doi:10.6084/m9.figshare.26671929
Zhang, L., Verwer, R. W. H., van Heerikhuize, J. J., Lucassen, P. J., Nathanielsz, P. W., Hol, E. M., Aronica, E., Dhillo, W. S., Meynen, G., & Swaab, D. F. (2024) · Figshare · doi:10.6084/m9.figshare.26671920
Zhang, L., Verwer, R. W. H., van Heerikhuize, J. J., Lucassen, P. J., Nathanielsz, P. W., Hol, E. M., Aronica, E., Dhillo, W. S., Meynen, G., & Swaab, D. F. (2024) · Figshare · doi:10.6084/m9.figshare.26671926
Zhang, L., Verwer, R. W. H., van Heerikhuize, J. J., Lucassen, P. J., Nathanielsz, P. W., Hol, E. M., Aronica, E., Dhillo, W. S., Meynen, G., & Swaab, D. F. (2024) · Figshare · doi:10.6084/m9.figshare.25052186
Zhang, L., Verwer, R. W. H., van Heerikhuize, J. J., Lucassen, P. J., Nathanielsz, P. W., Hol, E. M., Aronica, E., Dhillo, W. S., Meynen, G., & Swaab, D. F. (2024) · Figshare · doi:10.6084/m9.figshare.25052539
Zhang, L., Verwer, R. W. H., van Heerikhuize, J. J., Lucassen, P. J., Nathanielsz, P. W., Hol, E. M., Aronica, E., Dhillo, W. S., Meynen, G., & Swaab, D. F. (2024) · Figshare · doi:10.6084/m9.figshare.26671917
Zhang, L., Verwer, R. W. H., van Heerikhuize, J. J., Lucassen, P. J., Nathanielsz, P. W., Hol, E. M., Aronica, E., Dhillo, W. S., Meynen, G., & Swaab, D. F. (2024) · Figshare · doi:10.6084/m9.figshare.26671923
Salminen, Portin, & Nurmi, M. (2007) · Clinical Medicine Insights Oncology
Metadata
- Authors
- Shores, M. M., Moceri, V. M., Sloan, K. L., Matsumoto, A. M., & Kivlahan, D. R.
- Affiliations
- VA Puget Sound Health Care System (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2005-01-15
- Volume
- 66
- Issue
- 01
- Pages
- 7-14
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2033572273
- Cited by
- 166
- References
- 0
- Citations by year
- 2025: 3 · 2024: 12 · 2023: 4 · 2022: 6 · 2021: 4 · 2020: 7 · 2019: 10 · 2018: 10 · 2017: 15 · 2016: 7 · 2015: 9 · 2014: 6 · 2013: 10 · 2012: 8
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- androgen deficiency, hypogonadism, depression, older men, menopause, medical morbidity, age
- MeSH terms
- Age Factors, Aged, Depressive Disorder, Humans, Male, Middle Aged, Morbidity, Risk Factors, Testosterone, Geriatric Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.